06 Jul 2021

What’s in a label? Informing better decisions and avoiding greenwashing


S&P Global recently hosted their inaugural flagship Sustainable1 event, ‘Accelerating the Transition to Sustainability’, during which François Millet, Lyxor’s Head of ETF Strategy, ESG & Innovation shared his thoughts in a panel on ESG labels and how they can help avoid greenwashing. Read on for some edited highlights, or watch the full replay.

Panel agenda

  • What are the key considerations in product labelling? 
  • What can we learn from the EU Sustainable Finance Disclosure and Taxonomy Regulations? 
  • 2nd party opinions and avoiding greenwashing 


  • Lauren Smart, Chief Commercial Officer, ESG, S&P Global Sustainable1 (moderator)
  • Victor Van Hoorn, Executive Director, EuroSif
  • François Millet, Head of ETF Strategy, ESG and Innovation, Lyxor
  • Manjit Jus, Managing Director, Global Head of ESG Research & Data, S&P Global

Watch the full replay to learn more about investment labels, or read edited highlights below

Victor Van Hoorn on the state of European sustainability regulation 

Victor: “I think in the last couple of years, the EU and the European Commission has definitely taken a leadership role in this place. (…) That all stems from the post Paris Agreement on climate where it was obvious that we needed to leverage private finance besides public finance if we ever wanted to reach the climate neutrality goals. (…) In Europe there’s really two pieces of legislation that emerged. One was the much talked about EU Taxonomy which tries to come up with a classification system of economic activities that are aligned with the climate goals of climate neutrality. So in a way it seeks to define ‘green’, seeks to establish a harmonised consensus view of what we consider as sustainable enough or ‘green’ enough. (…) That’s complemented by the whole Sustainable Financial Disclosure Regulation, or SFDR, which is fast on track to revolutionise the market. (…) On the one hand it asks fund products that make promises around ESG or sustainable investment to disclose much more on the risk side of the equation, which is “explain to us how your investment portfolio is hedged or able to withstand risks that may be resulting from material ESG factors”. That’s one side. But the novelty I guess here is that it starts to also address the other side of materiality, which is more the impact question, where I think there has been much talk about the so called Principal Adverse Impact Indicators.”

François: “The ETF industry in Europe totals €1.1trn, and out of this, 12% are ESG ETFs (€130bn). But for net new assets it’s a different story – ESG ETFs represent 50% of the new assets gathered in the market, so it’s really a big transformation of the ETF market. What I can say and report is that the Disclosure Regulation which has been highlighted by Victor has been essential. (…) The classification of our products between products which are just promoting ESG characteristics and products which are more actively proposing sustainable investment objectives has been absolutely key. In the ETF space in Europe, less than 5% of the products are so called ‘Article 9’, the most demanding level. (…) We needed it to comply with three different frameworks for our products. The first one is European regulation, including Taxonomy regulation and of course Benchmark regulation for index products and Disclosure regulation (SDFR). The second one is the doctrines of local and domestic regulators who are willing to go further in specifying the constraints. In some countries like France for example we need to demonstrate the materiality of the ESG screening of the products, so the European regulation is not enough to get there. And thirdly, the labels. The labels are initiatives coming from various countries. They are so far domestic, and not only are they country specific, but they are not harmonised around Europe. So we are trying of course to build products, and sometimes we are negotiating with index providers to make sure they are integrating in the methodology of the indexes the criteria so that we are eligible to as many local labels as possible, but also to the European regulation of course.”

Manjit: “I think with regulation coming in Europe on what companies should be disclosing, and frameworks like TCFD offering a bit more guidance on the environmental pieces, that helps frame it. But certainly, a lot of the level of depth, if you really dig into it, will be required to meet the regulators’ needs. On the investors’ side (…) they can be quite in depth, at a very granular level in such a way that companies themselves may not have thought about in the past. (…) I also think this is an opportunity to really connect investors with companies, and bring them together around information that is necessary, because regulators are asking for it, and because hopefully it will drive more consistency and hopefully move the needle forward. I think this has an opportunity to shape the way companies are disclosing certain pieces of information, compared to some of the disaggregation and misalignment we’ve had in the past with different reporting standards that existed for companies that were not necessarily focused on investors.”

Lyxor has been active on the labelling front, with many of our ETFs being either SFDR 8 or 9 compliant, or having received ESG labels. We know sustainability criteria matter to you, and we’re doing everything we can to help avoid ‘greenwashing’.

We’re happy to report that two more ETFs in our ESG range recently received the official SRI Label:

This adds to our growing list of ESG credentials, including the SRI Label for our MSCI Europe ESG Leaders (DR) UCITS ETF and our MSCI EMU ESG Leaders Extra (DR) UCITS ETF, and the Greenfin Label for our flagship Green Bond (DR) UCITS ETF.

Watch this space as we continue with our ESG fund labelling programme throughout 2021 and beyond!

Risk Warning

This document is for the exclusive use of investors acting on their own account and categorised either as “Eligible Counterparties” or “Professional Clients” within the meaning of Markets in Financial Instruments Directive 2014/65/EU. These products comply with the UCITS Directive (2009/65/EC). Société Générale and Lyxor International Asset Management (LIAM) recommend that investors read carefully the “investment risks” section of the product’s documentation (prospectus and KIID). The prospectus and KIID are available free of charge on www.lyxoretf.com, and upon request to client-services-etf@lyxor.com.

Except for the United-Kingdom, where this communication is issued in the UK by Lyxor Asset Management UK LLP, which is authorized and regulated by the Financial Conduct Authority in the UK under Registration Number 435658, this communication is issued by Lyxor International Asset Management (LIAM), a French management company authorized by the Autorité des marchés financiers and placed under the regulations of the UCITS (2014/91/EU) and AIFM (2011/61/EU) Directives. Société Générale is a French credit institution (bank) authorised by the Autorité de contrôle prudentiel et de résolution (the French Prudential Control Authority). Lyxor International Asset Management (LIAM) is registered in the public register of the Netherlands Authority for the Financial Markets (Autoriteit Financiële Markten) as a manager (beheerder) of a UCITS.

The products mentioned are the object of market-making contracts, the purpose of which is to ensure the liquidity of the products on the London Stock Exchange, assuming normal market conditions and normally functioning computer systems. Units of a specific UCITS ETF managed by an asset manager and purchased on the secondary market cannot usually be sold directly back to the asset manager itself. Investors must buy and sell units on a secondary market with the assistance of an intermediary (e.g. a stockbroker) and may incur fees for doing so. In addition, investors may pay more than the current net asset value when buying units and may receive less than the current net asset value when selling them. Updated composition of the product’s investment portfolio is available on www.lyxoretf.com. In addition, the indicative net asset value is published on the Reuters and Bloomberg pages of the product, and might also be mentioned on the websites of the stock exchanges where the product is listed.

Prior to investing in the product, investors should seek independent financial, tax, accounting and legal advice. It is each investor’s responsibility to ascertain that it is authorised to subscribe, or invest into this product. This document is of a commercial nature and not of a regulatory nature. This material is of a commercial nature and not a regulatory nature. This document does not constitute an offer, or an invitation to make an offer, from Société Générale, Lyxor Asset Management (together with its affiliates, Lyxor AM) or any of their respective subsidiaries to purchase or sell the product referred to herein.

Research disclaimer

Lyxor International Asset Management (“LIAM”) or its employees may have or maintain business relationships with companies covered in its research reports. As a result, investors should be aware that LIAM and its employees may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investment decision. Please see appendix at the end of this report for the analyst(s) certification(s), important disclosures and disclaimers. Alternatively, visit our global research disclosure website www.lyxoretf.com/compliance.

Conflicts of interest

This research contains the views, opinions and recommendations of Lyxor International Asset Management (“LIAM”) Cross Asset and ETF research analysts and/or strategists. To the extent that this research contains trade ideas based on macro views of economic market conditions or relative value, it may differ from the fundamental Cross Asset and ETF Research opinions and recommendations contained in Cross Asset and ETF Research sector or company research reports and from the views and opinions of other departments of LIAM and its affiliates. Lyxor Cross Asset and ETF research analysts and/or strategists routinely consult with LIAM sales and portfolio management personnel regarding market information including, but not limited to, pricing, spread levels and trading activity of ETFs tracking equity, fixed income and commodity indices. Trading desks may trade, or have traded, as principal on the basis of the research analyst(s) views and reports. Lyxor has mandatory research policies and procedures that are reasonably designed to (i) ensure that purported facts in research reports are based on reliable information and (ii) to prevent improper selective or tiered dissemination of research reports. In addition, research analysts receive compensation based, in part, on the quality and accuracy of their analysis, client feedback, competitive factors and LIAM’s total revenues including revenues from management fees and investment advisory fees and distribution fees.